Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

NCT00704483 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Interventions

DRUG: SBR759
DRUG: Sevelamer HCl
DRUG: SBR759
DRUG: Sevelamer HCl

Sponsor

Novartis Pharmaceuticals